Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Aug;57(2):413–422.

Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype.

A M Lew, N A Staines, M W Steward
PMCID: PMC1536133  PMID: 6205798

Abstract

The work presented here represents the first report of the induction of experimental immune complex (IC) disease in mice using monoclonal antibodies (MoAb) derived from somatic cell hybridization. IC were formed using two antigens of either high (DNP19BSA) or low (DNP4BSA) epitope density and five MoAb (four IgGl with varying affinities for the dinitrophenol hapten and one IgM with a similar affinity to that of the lowest affinity IgGl). Circulating levels and sizes of IC were dependent on the affinity of the antibody component of the complex. When antigen of high epitope density was used, the glomerular localization of injected IC was diffuse mesangial for the IgM antibody, focal mesangial for the highest affinity IgG and diffuse, and predominantly capillary for the low affinity IgG antibodies. Subepithelial electron dense deposits were observed only with IC made with the low affinity IgG antibodies. When IC containing antigen of a lower epitope density were injected, localization was only observed with IC made near equivalence. Deposition of these IC was less prominent than that found when IC containing antigen of higher epitope density were injected. The relevance of these findings to the pathogenesis of glomerulonephritis is discussed.

Full text

PDF
413

Images in this article

416Fig. 1
on p.416
418Fig. 2
on p.418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron J. S. Glomerulonephritis: current problems and understanding. J Lab Clin Med. 1982 Jun;99(6):755–787. [PubMed] [Google Scholar]
  2. Couser W. G., Salant D. J. In situ immune complex formation and glomerular injury. Kidney Int. 1980 Jan;17(1):1–13. doi: 10.1038/ki.1980.1. [DOI] [PubMed] [Google Scholar]
  3. Devey M. E., Bleasdale K., Collins M., Steward M. W. Experimental antigen-antibody complex disease in mice. The role of antibody levels, antibody affinity and circulating antigen-antibody complexes. Int Arch Allergy Appl Immunol. 1982;68(1):47–53. doi: 10.1159/000233066. [DOI] [PubMed] [Google Scholar]
  4. Ford P. M. Passive serum sickness in the mouse: effect of interstrain differences on glomerular deposition of immune complexes. Br J Exp Pathol. 1975 Jun;56(3):199–204. [PMC free article] [PubMed] [Google Scholar]
  5. Gallo G. R., Caulin-Glaser T., Lamm M. E. Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest. 1981 May;67(5):1305–1313. doi: 10.1172/JCI110159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Germuth F. G., Jr, Rodriguez E., Lorelle C. A., Trump E. I., Milano L. L., Wise O. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits. Lab Invest. 1979 Oct;41(4):366–371. [PubMed] [Google Scholar]
  7. Haakenstad A. O., Striker G. E., Mannik M. The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology. 1982 Nov;47(3):407–414. [PMC free article] [PubMed] [Google Scholar]
  8. Haakenstad A. O., Striker G. E., Mannik M. The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest. 1976 Sep;35(3):293–301. [PubMed] [Google Scholar]
  9. Kijlstra A., Knutson D. W., Daha M. R., van Es L. A. Clearance and glomerular localization of preformed DNP anti-DNP immune complexes. Scand J Immunol. 1979;10(5):421–429. doi: 10.1111/j.1365-3083.1979.tb01371.x. [DOI] [PubMed] [Google Scholar]
  10. Koyama A., Niwa Y., Shigematsu H., Taniguchi M., Tada T. Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab Invest. 1978 Mar;38(3):253–262. [PubMed] [Google Scholar]
  11. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  12. MILLER F., BENACERRAF B., MCCLUSKEY R. T., POTTER J. L. Production of acute glomerulonephritis in mice with soluble antigen-antibody complexes prepared from homologous antibody. Proc Soc Exp Biol Med. 1960 Aug-Sep;104:706–709. doi: 10.3181/00379727-104-25960. [DOI] [PubMed] [Google Scholar]
  13. Okumura K., Kondo Y., Tada T. Studies on passive serum sickness. I. The glomerular fine structure of serum sickness nephritis induced by preformed antigen-antibody complexes in the mouse. Lab Invest. 1971 May;24(5):383–391. [PubMed] [Google Scholar]
  14. Stanley C., Lew A. M., Steward M. W. The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Methods. 1983 Nov 11;64(1-2):119–132. doi: 10.1016/0022-1759(83)90390-3. [DOI] [PubMed] [Google Scholar]
  15. Steward M. W. Chronic immune complex disease in mice: the role of antibody affinity. Clin Exp Immunol. 1979 Dec;38(3):414–423. [PMC free article] [PubMed] [Google Scholar]
  16. Wright N. G., Morrison W. I., Thompson H., Cornwell H. J. Experimental adenovirus immune complex glomerulonephritis. Br J Exp Pathol. 1973 Dec;54(6):628–633. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES